Commentary

In this commentary, Dr Rebecca Gottesman reviews the results of her ARIC-PET amyloid imaging study and explains what they mean for the future of clinical practice.

When considering potential drug interactions with statin therapy, it is important to consider the hepatic pathways that could be negatively impacted with the addition of new medications.

When considering potential drug interactions with statin therapy, it is important to consider the hepatic pathways that could be negatively impacted with the addition of new medications.

In this commentary, Janet Wei, MD, discusses results of The Cardiovascular Inflammation Reduction Trial and the impact of anti-inflammatory agents on reducing cardiovascular risk.

When patients present with signs and symptoms that raise suspicion for meningitis, primary care providers should ask about recent travel to Hawaii.

In this commentary, Robert Rosenson, MD, explains that PCSK9 inhibitors may be a useful alternative therapy in lowering LDL cholesterol in individuals who are unable to tolerate statins at the doses...

In this commentary, Jessica Tomaszewski, MD, discusses a Top Paper about the trend in US outpatient antibiotic prescriptions and what that means for practice.

Even with the arsenal of antibiotics and vaccines available in the 21st century, community-acquired pneumonia has lost none of its virulence.

In this commentary, M. Chiara Manzini, PhD, provides an overview of her research on gender bias in autism and why being aware of such bias is important for neurologists.

In this commentary, Vikas Majithia, MD, MPH, explains results of the PEXIVAS study and how they will impact the way rheumatologists treat patients with anti-neutrophil cytoplasm antibody-associated...